Question

What will be the vaccine efficacy of the two-dose Johnson & Johnson Ad26.COV2.S vaccine candidate according to the results of Phase III testing?

20 comments20

Total Forecasters32

Community Prediction89.8 (82.6 - 94.5)

Make a Prediction

This question is closed for predictions, and is waiting to be resolved

My Prediction

community

lower 25%

median

upper 75%

...

82.61

89.82

94.5

Learn more about scores here.

Authors:

juancambeiro

Opened:

Closed:

Scheduled resolution:

Phases of clinical research

Epidemiology

This drug is the 'breakthrough of the year' — and it could mean the end of the HIV epidemic

NPR Online News•Dec 13, 2024

SK Bioscience approved for Japanese encephalitis vaccine trial in Australia

Korea Herald•Dec 13, 2024

Biden gives Pfizer and Moderna shield from being sued for Covid vaccine injuries and deaths until 2029

Daily Mail•Dec 14, 2024

Learn more about Metaculus NewsMatch

How many total SARS-CoV-2 mRNA vaccine doses will the US FDA and CDC recommend for at least 15% of the US on December 31, 2024?

8.11

Before June 2032, will the US FDA authorize a vaccine without phase III efficacy data in response to a new public health emergency?

Before 2032, will these pan-coronavirus vaccine candidates be approved by the USA, UK, EU, or Canada?

Comments

? comments

Authors:

juancambeiro

Opened:

Closed:

Scheduled resolution:

Phases of clinical research

Epidemiology

This drug is the 'breakthrough of the year' — and it could mean the end of the HIV epidemic

NPR Online News•Dec 13, 2024

SK Bioscience approved for Japanese encephalitis vaccine trial in Australia

Korea Herald•Dec 13, 2024

Biden gives Pfizer and Moderna shield from being sued for Covid vaccine injuries and deaths until 2029

Daily Mail•Dec 14, 2024

Learn more about Metaculus NewsMatch

How many total SARS-CoV-2 mRNA vaccine doses will the US FDA and CDC recommend for at least 15% of the US on December 31, 2024?

8.11

Take Our 🏆Quarterly Cup🏆 Survey

MetaculusM

What will be the vaccine efficacy of the two-dose Johnson & Johnson Ad26.COV2.S vaccine candidate according to the results of Phase III testing?

Make a Prediction

How many total SARS-CoV-2 mRNA vaccine doses will the US FDA and CDC recommend for at least 15% of the US on December 31, 2024?

Before June 2032, will the US FDA authorize a vaccine without phase III efficacy data in response to a new public health emergency?

Before 2032, will these pan-coronavirus vaccine candidates be approved by the USA, UK, EU, or Canada?

Comments

How many total SARS-CoV-2 mRNA vaccine doses will the US FDA and CDC recommend for at least 15% of the US on December 31, 2024?

Before June 2032, will the US FDA authorize a vaccine without phase III efficacy data in response to a new public health emergency?

Before 2032, will these pan-coronavirus vaccine candidates be approved by the USA, UK, EU, or Canada?

How many total SARS-CoV-2 mRNA vaccine doses will the US FDA and CDC recommend for at least 15% of the US on December 31, 2024?

Before June 2032, will the US FDA authorize a vaccine without phase III efficacy data in response to a new public health emergency?

Before 2032, will these pan-coronavirus vaccine candidates be approved by the USA, UK, EU, or Canada?

How many total SARS-CoV-2 mRNA vaccine doses will the US FDA and CDC recommend for at least 15% of the US on December 31, 2024?

Before June 2032, will the US FDA authorize a vaccine without phase III efficacy data in response to a new public health emergency?

Before 2032, will these pan-coronavirus vaccine candidates be approved by the USA, UK, EU, or Canada?